Job title: CSO
Dr. Zago has served as Prothena’s Chief Scientific Officer since 2017, overseeing the neuroscience company’s research and drug discovery efforts. He joined Prothena in 2012 when the company was founded, first as Head of Pharmacology and Neuropathology and later as Vice President, Head of Research. Dr. Zago was Principal Scientist at Elan Pharmaceuticals, Inc. While in this position, between 2009 and 2013, he also served as a Scientist at Janssen Alzheimer Immunotherapy.
Embarking on a New Era of Immunotherapy for Proteinopathies 9:30 am
Focusing on the evidence that antibodies can reduce extracellular and intraneuronal accumulation of protein aggregates and prevent neurodegeneration Reviewing the current clinical landscape of immunotherapeutics being tested in neurodegenerative diseases Read more
day: Day Two